Schuth Alexander O. 4
4 · Denali Therapeutics Inc. · Filed Aug 14, 2025
Insider Transaction Report
Form 4
Schuth Alexander O.
COFO and Secretary
Transactions
- Sale
Common Stock
2025-08-12$13.58/sh−2,937$39,884→ 242,346 total
Holdings
- 523,749(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
- [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $13.35 to $13.58 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]Includes 128,405 Unvested RSUs.
- [F4]Includes 975 shares acquired under the ESPP Purchase on June 2, 2025.
- [F5]The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.